BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10837485)

  • 41. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin).
    Mosesson MW; DiOrio JP; Müller MF; Shainoff JR; Siebenlist KR; Amrani DL; Homandberg GA; Soria J; Soria C; Samama M
    Blood; 1987 Apr; 69(4):1073-81. PubMed ID: 3548843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):976-82. PubMed ID: 3365374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin.
    Shainoff JR; Smejkal GB; DiBello PM; Sung SS; Bush LA; Di Cera E
    J Biol Chem; 2002 May; 277(22):19367-73. PubMed ID: 11891217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
    Llobet D; Borrell M; Vila L; Vallvé C; Felices R; Fontcuberta J
    Haematologica; 2007 Feb; 92(2):e17-9. PubMed ID: 17405747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
    Ni F; Zhu Y; Scheraga HA
    J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
    Cooper AV; Standeven KF; Ariëns RA
    Blood; 2003 Jul; 102(2):535-40. PubMed ID: 12663453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.
    Ribes JA; Ni F; Wagner DD; Francis CW
    J Clin Invest; 1989 Aug; 84(2):435-42. PubMed ID: 2788172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.
    Mihalyi E; Tercero JC; Diaz-Mauriño T
    Biochemistry; 1991 May; 30(19):4753-62. PubMed ID: 2029517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of bilineobin, a thrombin-like proteinase from the venom of common cantil (Agkistrodon bilineatus).
    Komori Y; Nikai T; Ohara A; Yagihashi S; Sugihara H
    Toxicon; 1993 Mar; 31(3):257-70. PubMed ID: 8470131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin.
    De Cristofaro R; Castagnola M
    Haemostasis; 1991; 21(2):85-90. PubMed ID: 1959802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
    Harada K; Orita T; Abiko S; Aoki H
    Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
    Lewis SD; Shafer JA
    Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on the thrombin-like enzyme preferentially releasing fibrinopeptide B from the snake venom of Agkistrodon halys Pallas.
    Guan LF; Chi CW; Yuan M
    Thromb Res; 1984 Aug; 35(3):301-10. PubMed ID: 6463961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42.
    Hamaguchi M; Bunce LA; Sporn LA; Francis CW
    Blood; 1993 May; 81(9):2348-56. PubMed ID: 8481515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.